Nov 14, 2023 / 09:30PM GMT
Operator
Good afternoon, ladies and gentlemen, and welcome to the TFF Pharmaceuticals third quarter 2023 corporate update and earnings conference call. As a reminder, this conference is being recorded. I will now turn the call over to our host, Corey Davis with LifeSci Advisors. You may begin your conference.
Corey Davis - LifeSci Advisors, LLC - IR
Thank you, operator. Hello, everyone, and welcome to TFF Pharmaceuticals third quarter 2023 Corporate update and earnings conference call. With me on the line this afternoon, Dr. Harlan Weisman, Chief Executive Officer of TFF Pharmaceuticals; Dr. Zamaneh Mikhak, Chief Medical Officer; and Kirk Coleman, Chief Financial Officer.
Before we get started, I'd like to remind everyone that this call will contain forward-looking statements, including without limitation, statements about the anticipated timing of achievement of clinical milestones, the potential to see positive effects in our Phase 2 studies, a number of treated patients necessary to make decisions in regards to moving to Phase 3 studies, the market
Q3 2023 TFF Pharmaceuticals Inc Earnings Call Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers